The 36-month beta value for INSP is at 1.42. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 3 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for INSP is 29.66M, and currently, shorts hold a 7.80% of that float. The average trading volume for INSP on May 08, 2024 was 481.58K shares.
INSP) stock’s latest price update
Inspire Medical Systems Inc (NYSE: INSP)’s stock price has decreased by -34.44 compared to its previous closing price of 245.63. However, the company has seen a -34.00% decrease in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-08 that While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
INSP’s Market Performance
INSP’s stock has fallen by -34.00% in the past week, with a monthly drop of -32.41% and a quarterly drop of -20.34%. The volatility ratio for the week is 4.02% while the volatility levels for the last 30 days are 4.65% for Inspire Medical Systems Inc The simple moving average for the last 20 days is -32.21% for INSP stock, with a simple moving average of -19.27% for the last 200 days.
Analysts’ Opinion of INSP
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see INSP reach a price target of $285. The rating they have provided for INSP stocks is “Outperform” according to the report published on April 19th, 2024.
Morgan Stanley gave a rating of “Overweight” to INSP, setting the target price at $250 in the report published on March 19th of the current year.
INSP Trading at -25.22% from the 50-Day Moving Average
After a stumble in the market that brought INSP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.20% of loss for the given period.
Volatility was left at 4.65%, however, over the last 30 days, the volatility rate increased by 4.02%, as shares sank -33.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.58% lower at present.
During the last 5 trading sessions, INSP fell by -34.50%, which changed the moving average for the period of 200-days by -44.71% in comparison to the 20-day moving average, which settled at $233.55. In addition, Inspire Medical Systems Inc saw -20.84% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INSP starting from Buchholz Richard, who sale 15,000 shares at the price of $230.03 back on Apr 17 ’24. After this action, Buchholz Richard now owns 28,271 shares of Inspire Medical Systems Inc, valued at $3,450,450 using the latest closing price.
Herbert Timothy P., the CEO and President of Inspire Medical Systems Inc, sale 40,000 shares at $205.09 during a trade that took place back on Apr 01 ’24, which means that Herbert Timothy P. is holding 63,658 shares at $8,203,581 based on the most recent closing price.
Stock Fundamentals for INSP
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.85 for the gross margin
The net margin for Inspire Medical Systems Inc stands at -0.02. The total capital return value is set at -0.06. Equity return is now at value -2.88, with -2.50 for asset returns.
Based on Inspire Medical Systems Inc (INSP), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 1.42. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -8.39.
Currently, EBITDA for the company is -40.27 million with net debt to EBITDA at 6.3. When we switch over and look at the enterprise to sales, we see a ratio of 7.23. The receivables turnover for the company is 9.14for trailing twelve months and the total asset turnover is 0.96. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.93.
Conclusion
In conclusion, Inspire Medical Systems Inc (INSP) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
